Formulation and evaluation of bioadhesive buccal drug delivery of repaglinide tablets

Main Article Content

Dasharath M Patel
Pratik M Shah
Chhagan N Patel


The purpose of this research was to formulate and evaluate bioadhesive buccal tablets of repaglinide using HPMC K15M as a sustained release polymer, chitosan as a bioadhesive polymer and ethyl cellulose as an impermeable backing layer.
The tablets were evaluated for weight variation, thickness, hardness, friability, surface pH, mucoadhesive strength, swelling index, in vitro drug release, ex vivo mucoadhesion time and ex vivo drug permeation. A 32 full factorial design was used in present study for optimization. Tablets containing HPMC K15M and chitosan in the ratio of 1:1 and lactose as a filler (F2) had the maximum percentage of in vitro drug release. The swelling index, friability and in vitro drug release was affected by type of filler as dicalcium phosphate (DCP) had good binding ability compared to lactose. The surface pH of all tablets
was found to be satisfactory (between 6.26 and 7.01), close to neutral pH; hence buccal cavity irritation should not occur with these tablets. F2 batch was considered optimum based on good bioadhesive strength (17.83±0.51 gm) and maximum similarity factor (64.43).The drug release from optimum batch followed zero order kinetics with non-Fickian diffusion. Drug-excipients compatibility study showed no interaction between drug and excipients. Stability study of optimized formulation showed that tablets were stable at accelerated environment condition. Thus, buccal adhesive tablet of repaglinide could be an alternative route to bypass hepatic first pass metabolism and to improve bioavailability of repaglinide.


Download data is not yet available.

Article Details

How to Cite
Patel, D. M., Shah, P. M., & Patel, C. N. (2014). Formulation and evaluation of bioadhesive buccal drug delivery of repaglinide tablets. Asian Journal of Pharmaceutics (AJP), 6(3).


Roy S, Pal K, Anis A, Pramanik K, Prabhakar B. Polymers in mucoadhesive drug delivery system: A brief note. Designed Monomers Polymers 2009;12:483-95.

Kaelbe DH, Moacanin J. A surface energy analysis of bioadhesion.

Polymer 1977;18:475-82.

Gu JM, Robinson JR, Leung S. Binding of acrylic polymers to mucin/

epithelial surfaces: Structure-property-relationship. Crit Rev Ther Drug

Carrier Syst 1988;5:21-67.

Duchene D, Touchard F, Peppas NA. Pharmaceutical and medical aspects

of Bioadhesive system for drug administration. Drug Dev Ind Pharm


Leung SH, Robinson JA. Polyanionic polymers in bioadhesive and

mucoadhesive drug delivery. ACS Symp Ser 1992;480:269-84.

Al-Achi A, Greenwood R. Buccal administration of human insulin in

streptozocin-diabetic rats. Res Commun Chem Pathol Pharmacol


Bouckaert S, Remon JP. In-vitro bioadhesion of a buccal, miconazole

slow-release tablet. J Pharm Pharmacol 1993;45:504-7.

Bhanja S, Ellaiah P, Martha SK, Sahu PK, Tiwari SP, Panigrahi BB, et al.

Formulation and in vitro evaluation of mucoadhesive buccal tablets of

Timolol maleate. Int J Pharm Biomed Res 2010;1:129-34.

Karavana SY, Guneri P, Ertan G. Benzydamine hydrochloride buccal

bioadhesive gels designed for oral ulcers: Preparation, rheological,

textural, mucoadhesive and release properties. Pharm Dev Technol


Petelin M, Pavlica Z, Bizimoska S, Sentjurc S. In vivo study of different

ointments for drug delivery into oral mucosa by EPR oximetry. Int J

Pharm 2004;270:83-91.

Consuelo ID, Falson F, Guy RH, Jacques Y. Ex vivo evaluation of

bioadhesive films for buccal delivery of fentanyl. J Control Release


Nafee NA, Ismail FA, Boraie NA, Mortada LM. Mucoadhesive buccal

patches of miconazole nitrate: In vitro/in vivo performance and effect

of ageing. Int J Pharm 2003;264:1-14.

Parodi B, Russo E, Caviglio G, Caffaggi S, Bignardi G. Development

and characterization of a buccoadhesive dosage form of oxycodone

hydrochloride. Drug Dev Ind Pharm 1996;22:445-50.

van Heiningen PN, Hatorp V, Nielsen KK, Hansen KT, van Lier JJ, van

De Merbel NC, et al. Absorption, metabolism and excretion of a single. oral dose of 14C-repaglinide during repaglinide multiple dosing. Eur J

Clin Pharmcol 1999;55:521-5.

Vaghani SS, Patel SG, Jivani RR, Jivani NP, Patel MM, Borda R. Design and optimization of a stomach specific drug delivery system of repaglinide:

Application of simplex lattice design. Pharm Dev Technol 2012;17:55-65.

Makino C, Sakai H, Yabuki A. Nateglinide controlled release tablet

containing compressionable enteric coated granules. Chem Pharm Bull


Makino C, Sakai H, Yabuki A. Design of Nateglinide Controlled Release

tablet containing erosion matrix tablet and multiple administration

study in Normal beagle dogs. Chem Pharm Bull 2009;57:907-13.

Hatorp V, Oliver S, Su CA. Bioavailability of repaglinide, a novel

antidiabetic agent, administered orally in tablet or solution form or

intravenously in healthy male volunteers. Int J Clin Pharmacol Ther


Basak SC, Karthikeyan J, Bhusan B. Design, in vitro evaluation and

release rate kinetics of matrix type sustained release tablet containing

aceclofenac. The Internet Journal of Pharmacology 2010. Available from:



[Last accessed on 2012 Apr 12].

Robinson JR, Eriksen SP. Theoratical formulation of sustained dosage

forms. J Pharm Sci 1966;55:1254-63.

Rajput SJ, Chaudhary BG. Validated analytical methods of repaglinide

in bulk and tablet formulations. Indian J Pharm Sci 2006;68:130-2.

Gupta A, Garg S, Khar RK. Measurements of bioadhesive strength of

mucoadhesive buccal tablets: Design of an in vitro assembly. Indian

Drugs 1993;30:152-5.

Tirosh B, Baluom M, Nasar T, Friedman M, Rubinstein A. The effect of

Eudragit RL-100 on the mechanical and mucoadhesion properties of

Polycarbophil dosage forms. J Control Release 1997;45:57-64.

Ritthidej GC, Phaechamud T, Koizumi T. Moist heat treatment on

physiological change of chitosan salt films. Int J Pharm 2002;232:11-22.

Bottemberg P, Cleymaet R, Muyenk CD, Remon JP, Coomans D, Slop D.

Development and testing of bioadhesive, fluoride containing slow-

release tablets for oral use. J Pharm Pharmacol 1991;43:457-64.

Patel VM, Prajapati BG, Patel HV, Patel KM. Mucoadhesive bilayer tablets of propranolol hydrochloride. AAPS PharmSciTech 2007;8:E1-6.

Coasta P, Manuel J, Labao S. Modeling and comparison of dissolution

profiles. Eur J Pharm Sci 2002;13:123-33.

Higuchi T. Mechanism of sustained action mediation, theoretical

analysis of rate of release of solid drugs dispersed in solid matrices.

J Pharm Sci 1963;52:1145-9.

Hixon AW, Crowell JH. Dependence of reaction velocity upon surface

and agitation. Ind Engg Chem 1931;23:923-31.

Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanism

of solute release from porous hydrophillic polymers. Int J Pharm


Ilango R, Kavimani S, Mullaincharam AR, Jayakar B. In vitro studies

on buccal strips of glibenclamide using chitosan. Indian J Pharm Sci